top of page

human hepatocytes

At Preci, we deliver high-quality human hepatocytes designed to meet the diverse and stringent demands of modern drug metabolism and pharmacokinetics (DMPK) studies. Our hepatocyte solutions are tailored for researchers seeking reliability, scalability, and consistency without compromising scientific rigor.

​

- >80% viable cells upon thawing - >8 mln cells/vial - Confluent monolayer within 24 hours - mRNA-based CYP1A2, CYP2B6, CYP3A4 at least 10-fold - Microbial sterility - HBV/HCV/HIV-free

Pooled-5 Plateable Hepatocytes

Read More
- >85% viability upon thawing - >5 mln cells/vial - Qualified for the population-average CYP activity (CYP1A2; CYP2A6; CYP2B6; CYP2C8; CYP2C9; CYP2E1; CYP3A4/5; CYP3A4/5) - Stable for at least 6 hours in suspension culture - Sterile; HBV/HCV/HIV-free

Pooled Human Hepatocytes (20-donor pool)

Read More
>85% viability upon thawing >8 mln cells/vial Confluent monolayer within 24 hours Microbial sterility HBV/HCV/HIV-free

Transporter-Qualified Plateable Human Hepatocytes

Read More
- >85% viability upon thawing - >5 mln cells/vial - Qualified for the population-average CYP activity (CYP1A2; CYP2A6; CYP2B6; CYP2C8; CYP2C9; CYP2E1; CYP3A4/5; CYP3A4/5) - Stable for at least 6 hours in suspension culture - Sterile; HBV/HCV/HIV-free

Pooled Human Hepatocytes (10-donor pool)

Read More
- >85% viable cells upon thawing - >8 mln cells/vial - Confluent monolayer within 24 hours - mRNA-based CYP1A2, CYP2B6, CYP3A4 at least 10-fold - Microbial sterility - HBV/HCV/HIV-free

Induction-Qualified Plateable Human Hepatocytes

Read More
bottom of page